294 related articles for article (PubMed ID: 28716934)
1. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
[TBL] [Abstract][Full Text] [Related]
2. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists.
Tejada MÁ; Montilla-García Á; González-Cano R; Bravo-Caparrós I; Ruiz-Cantero MC; Nieto FR; Cobos EJ
Pharmacol Res; 2018 May; 131():224-230. PubMed ID: 29454675
[TBL] [Abstract][Full Text] [Related]
3. Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors.
Tejada MA; Montilla-García A; Sánchez-Fernández C; Entrena JM; Perazzoli G; Baeyens JM; Cobos EJ
Psychopharmacology (Berl); 2014 Oct; 231(19):3855-69. PubMed ID: 24639046
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
5. S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice.
Gris G; Merlos M; Vela JM; Zamanillo D; Portillo-Salido E
Behav Pharmacol; 2014 Jun; 25(3):226-35. PubMed ID: 24776490
[TBL] [Abstract][Full Text] [Related]
6. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
Shinohara A; Andoh T; Saiki I; Kuraishi Y
Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
[TBL] [Abstract][Full Text] [Related]
7. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
Entrena JM; Cobos EJ; Nieto FR; Cendán CM; Baeyens JM; Del Pozo E
Psychopharmacology (Berl); 2009 Jul; 205(1):21-33. PubMed ID: 19326101
[TBL] [Abstract][Full Text] [Related]
8. TRPV1 promotes opioid analgesia during inflammation.
Basso L; Aboushousha R; Fan CY; Iftinca M; Melo H; Flynn R; Agosti F; Hollenberg MD; Thompson R; Bourinet E; Trang T; Altier C
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940767
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of morphine-induced mechanical antinociception by σ₁ receptor inhibition: role of peripheral σ₁ receptors.
Sánchez-Fernández C; Nieto FR; González-Cano R; Artacho-Cordón A; Romero L; Montilla-García Á; Zamanillo D; Baeyens JM; Entrena JM; Cobos EJ
Neuropharmacology; 2013 Jul; 70():348-58. PubMed ID: 23524304
[TBL] [Abstract][Full Text] [Related]
10. The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.
Paranos SLj; Tomić MA; Micov AM; Stepanović-Petrović RM
Fundam Clin Pharmacol; 2013 Jun; 27(3):319-28. PubMed ID: 22136176
[TBL] [Abstract][Full Text] [Related]
11. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
[TBL] [Abstract][Full Text] [Related]
12. Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats.
Bileviciute-Ljungar I; Spetea M
Br J Pharmacol; 2001 Jan; 132(1):252-8. PubMed ID: 11156584
[TBL] [Abstract][Full Text] [Related]
13. The sigma-1 receptor curtails endogenous opioid analgesia during sensitization of TRPV1 nociceptors.
Ruiz-Cantero MC; Cortés-Montero E; Jain A; Montilla-García Á; Bravo-Caparrós I; Shim J; Sánchez-Blázquez P; Woolf CJ; Baeyens JM; Cobos EJ
Br J Pharmacol; 2023 Apr; 180(8):1148-1167. PubMed ID: 36478100
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
15. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
16. Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats.
Huang J; Cai Q; Chen Y; Hong Y
Brain Res; 2009 Dec; 1303():39-47. PubMed ID: 19782054
[TBL] [Abstract][Full Text] [Related]
17. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
18. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
19. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
20. The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system.
Landa-Juárez AY; Pérez-Severiano F; Castañeda-Hernández G; Ortiz MI; Chávez-Piña AE
Eur J Pharmacol; 2019 Feb; 845():32-39. PubMed ID: 30582909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
